510(k) K812327
K812327 is an FDA 510(k) premarket notification submitted by Kallestad Laboratories, Inc. for the device "KAPPA & LAMBDA BENCE JONES CONTROLS". The FDA issued a decision of Substantially Equivalent on September 1, 1981. The device falls under product code CZQ (Bence-Jones Protein, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5150. Kallestad Laboratories, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 1, 1981
- Date Received
- August 18, 1981
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Bence-Jones Protein, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5150
- Review Panel
- IM
- Submission Type